James Chung
Director Técnico/Científico/I+D en KYVERNA THERAPEUTICS, INC. .
Fortuna: 1 M $ al 30/04/2024
Perfil
James Chung is currently the Chief Medical Officer at Kyverna Therapeutics, Inc. Prior to this, he worked as an Executive Director-Medical at Amgen, Inc. and as an Associate Director-Clinical Sciences at Pfizer Inc. He holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Harvard College.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/03/2024 | 65 918 ( 0.15% ) | 1 M $ | 30/04/2024 |
Cargos activos de James Chung
| Empresas | Cargo | Inicio |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/04/2021 |
Antiguos cargos conocidos de James Chung.
| Empresas | Cargo | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
| AMGEN INC. | Director Técnico/Científico/I+D | - |
Formación de James Chung.
| University of Pennsylvania | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| KYVERNA THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| PFIZER, INC. | Health Technology |
- Bolsa de valores
- Insiders
- James Chung
